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In This IssueEnhancers Take Charge of Cell Fate
Reprogramming
PAGE 1282
Taberlay et al. reveal an unexpected role for enhancers in cell fate reprogram-
ming. Enhancers of Polycomb-repressed genes have nucleosome-depleted
regions that provide an entry point for the initial binding of transcriptional
regulators. These regulators subsequently access their target promoters via
enhancer-promoter interactions to trigger transcription and cell fate reprogram-
ming. Chromatin accessibility for reprogramming therefore begins at the
enhancers.Inheriting Antiviral RNA
PAGE 1248
Rechavi et al. show that C. elegans are capable of directly transmitting antiviral
small interfering RNAs to their progeny, conveying the memory of a viralencounter to subsequent generations to enable them to respond more effectively when challenged with the same infection.
The ability to inherit this extragenic information presents a potential adaptive benefit to the host.Promoter Melting at First Sight
PAGE 1257
The key steps in bacterial transcription initiation are recognition of the 10 promoter element by the s subunit of the RNA
polymerase holoenzyme and melting of the DNA to enable RNA synthesis. Feklistov and Darst report structural analysis of
a single-stranded 10 element DNA bound to s, revealing that these two processes are not distinct but that, surprisingly,
promoter recognition and DNA melting are coupled.Potential New Therapeutic for Liver Cancer
PAGE 1233
Hepatocyte nuclear factor 4a (HNF4a) is essential for liver development and hepatocyte function. Hatziapostolou et al. now
show that transient inhibition of HNF4a stabilizes a microRNA-inflammatory feedback circuit and transforms hepatocytes,
promoting liver cancer. Systemic administration of miR-124, an miRNA that acts downstream of HNF4a, induces apoptosis
of oncogenic hepatocytes in two mouse models of liver cancer, highlighting the therapeutic potential of modulating this
miRNA-inflammatory circuit.SNAREing Peptides for Crosspresentation
PAGE 1355Antigen crosspresentation is essential for triggering T cell-mediated immunity to
certain pathogens and involves the export of antigens fromphagocytosed path-
ogens to the cytosol. Savina et al. identify a critical role for the SNARESec22b in
crosspresentation by dendritic cells, defining a trafficking pathway linking the
ER-Golgi intermediate compartment to phagosomes, which is distinct from
other antigen presentation pathways and is specific for crosspresentation.Choosing When to Pull the Trigger
PAGE 1295
Oh et al. use ribosomal profiling to get a quantitative and dynamic view of the
engagement of the E. coli chaperone trigger factor (TF) with nascent polypep-
tides in vivo. They find that TF engages polypeptides only after 100 amino
acids have emerged from the ribosome exit tunnel rather than immediately
upon exit. The findings support a model in which proper protein biogenesis
relies on sequential engagement of different processing and folding factors
during translation.Cell 147, December 9, 2011 ª2011 Elsevier Inc. 1199
Ubiquitin Turns On Translation
PAGE 1369
Pavlopoulos et al. find that ubiquitination can affect synaptic plasticity by activating
protein function, in addition to its known role of targeting proteins for degradation.
Neuralized1, a mouse E3 ubiquitin ligase, monoubiquitinates and activates CPEB3,
a translational regulator that promotes the production of AMPA receptor subunits,
leading to an increase in the formation of dendritic spines in hippocampal neurons,
as well as enhanced hippocampal-dependent memory and plasticity.
A Rise to STARDom for Combination Therapy
PAGE 1309
Despite having success in treating cancer, current antimitotic drugs like paclitaxel
have unintended toxicity. Through focused proteomic and genetic screens, Torres
et al. identify STARD9 as a new kinesin with a role in maintaining the pericentriolarmaterial during mitosis. Loss of STARD9 synergizes with paclitaxel, implicating this protein as a candidate therapeutic target
for combination therapy with increased specificity for proliferating cells.
Lost Tankyrase Targeting Explains Cherubism
PAGE 1324 and PAGE 1340
Cherubism is an autosomal dominant syndrome, characterized by bony lesions and facial deformities, that is caused bymuta-
tions in the adapter protein 3BP2. Levaot et al. show that cherubismmutations uncouple 3BP2 from thepoly (ADP-ribose) poly-
merase Tankyrase, stabilizing 3BP2 and hyperactivating several signaling pathways in osteoclasts. In a related paper, Guettler
et al. crystallize the substrate recognitionmodule of Tankyrase bound tomultiple substrates and derive a substrate consensus
sequence that explains the basis of the cherubism-causing mutations in 3BP2 and predicts other Tankyrase targets.
PKR Inhibition Makes Mice Smarter
PAGE 1384
The brains of patients with age-related memory loss exhibit excessive activity of the kinase PKR. Zhu et al. now connect
increased PKR activity with high levels of eIF2a signaling, enhanced GABAergic inhibitory discharges, and decreased
neuronal network excitability. Pharmacological inhibition of PKR enhances learning and memory in mice, pointing to this
kinase as a promising target for the treatment of memory loss and cognitive disorders.
Severance for the Downsized Spindle
PAGE 1397
Loughlin et al. combine computational modeling with biochemical experiments to elucidate the mechanism that sets meiotic
spindle size in two species of frogs that have oocytes of different sizes. They find that differential regulation of katanin, amicro-
tubule-severing protein, leads to a more active enzyme in the smaller oocytes, resulting in faster microtubule depolymeriza-
tion and a shorter spindle.
ChIP in Full HD
PAGE 1408Unveiling ChIP-exo, Rhee et al. demonstrate how trimming ChIP-DNA with exonucle-
ases resolves DNA binding site boundaries at single base pair resolution and reduces
rates of false positives and negatives. They provide an unambiguous, genome-wide
view of binding sites for multiple transcription factors, revealing diverse ways in which
binding specificity is achieved.
SELEX-tivity for Hox Binding
PAGE 1270
The different members of the Hox family of transcription factors have similar
DNA binding preferences but carry out distinct functions in vivo. Slattery et al. use
SELEX-seq to characterize DNA binding specificities of Hox proteins individually
and bound to their common cofactor Exd and show that this heterodimerization
confers different sequence preferences. These findings provide a paradigm for how
in vivo sequence specificity is established within transcription factor families.Cell 147, December 9, 2011 ª2011 Elsevier Inc. 1201
